Jump to content


This stream auto-updates     

  1. Today
  2. This fact sheet provides information for immunisation providers on measles disease and measles vaccination in Australia.
  3. Last week
  4. In the process of learning more about vaccines, parents — and some healthcare providers — are sometimes surprised to find out that fetal cells are used during the manufacturing process for a few vaccines. This piece provides answers to several questions.
  5. Earlier
  6. Vaccination is one of the most successful and cost-effective advances in global public health. Vaccines are given to many millions of people in Australia and billions worldwide to prevent disease. Vaccines prevent an estimated 2 to 3 million deaths every year. This document provides answers to many common questions about vaccination. It is designed: to help parents find out more about vaccines and the most recent evidence about their safety and effectiveness. to help doctors answer questions from their patients.
  7. This fact sheet is about the safety of the HPV vaccine. It provides information about: the need for the HPV vaccine the effectiveness of the HPV vaccine common questions about the HPV vaccine. The fact sheet was developed to help doctors and nurses to answer parents' questions about vaccinations. References and links to further reading are included.
  8. This fact sheet explains how we know vaccination does not cause autism and where the misunderstanding came from. Many large studies have found vaccines do not cause autism. References and links to further reading are included. This fact sheet provides information about: how we know vaccination does not cause autism that why some children develop autism is still not understood where the misunderstanding that vaccination causes autism came from. The fact sheet was developed to help doctors and nurses to answer parents' questions about vaccinations.
  9. This fact sheet has been developed for nurses and doctors is about how vaccines are shown to be safe, noting how all vaccines are carefully tested. It provides information about: how vaccines are tested how side effects are detected what happens if there is a suspected problem with a vaccine. The fact sheet was developed to help doctors and nurses to answer parents' questions about vaccinations. References and links to further reading are included.
  10. This fact sheet is about vaccine ingredients. This fact sheet considers vaccine safety and ingredients including: antigens adjuvants preservatives stabilisers residues diluents. The fact sheet was developed to help doctors and nurses to answer parents' questions about vaccinations. References and links to further reading are included.
  11. The Guide presents recommendations for vaccine safety communication with a specific focus on regulatory bodies.
  12. This short video, shown as a #throwback social media content to drum up the World Immunization Week 2019 celebration, describes the success of vaccination in eradicating polio. The video is told in the point-of-view of the Philippines context. The Philippines was certified polio-free since year 2000, yet the threat of this paralyzing disease still remains. As long as poliovirus transmission happens elsewhere in the world, all other children remain at risk. The video calls that all children in communities should complete their polio vaccines.
  13. This short video, shown as a #throwback social media content to drum up the World Immunization Week 2019 celebration, describes the success of vaccination in the global eradication of smallpox. It features a piece of public health history in the Philippines, when the smallpox vaccines first arrived in the country during the Spanish colonial period. Through a global vaccination programme, smallpox was officially declared as eradicated in 1979.
  14. Recommandations en population générale pour la vaccination contre la rougéole.
  15. Courrier à l’attention des parents d’élèves, familles et professionnels au contact d’enfants, jeunes adultes, femmes enceintes et personnes immunodéprimées.
  16. Documents concernant la conduite à tenir en cas de rougéole. Ils sont destinés aux établissements scolaires et de la petite enfance et à toute autre établissement.
  17. Matériel de communication concernant le vaccin contre la rougéole.
  18. Filipinos have a penchant for singing and dancing, hence the education-entertainment approach was used in communicating key themes on immunization. The Department of Health in the Philippines, with support from the World Health Organization, produced the following music videos for the Back to Bakuna (Back to Vaccines) campaign in 2017: Bakwagon (a word play on Bakuna/Vaccine and wagon), a public service announcement aired on TV and radio Baby Come Bak (Baby Come Back), on convincing parents and caregivers to complete their baby's vaccination Limang Bisita (Five Visits), on the schedule of immunization visits May Bakuna para D'yan (There's a Vacccine for That), on vaccines and diseases they prevent Okay Kay Baby (Okay for Baby), on vaccine safety. This music video is not included in the playlist but is exclusively played at health facilities. The music videos are being played at waiting areas of health centers, to supplement the information needs of parents and caregivers while they wait for their child to be vaccinated.
  19. This is a compliation of field guides developed to support communication planners and programme implementers in their communications around human papillomavirus (HPV) vaccination introduction, planning, roll out, and monitoring. They are the result of a collaboration between the United Nations Children's Fund (UNICEF), GAVI, the World Health Organization (WHO), PATH, Girl Effect, the Centers for Disease Control and Prevention (CDC), Clinton Health Access Initiative (CHAI), Jhpiego, United Nations Population Fund (UNFPA), the Bill and Melinda Gates Foundation, American Cancer Society, and PCI Media. Field Guide - HPV Message Framework Field Guide - Interpersonal Communication for HPV Field Guide - HPV Vaccination Branding Field Guide - Digital Dialogue for HPV Vaccination Field Guide - HPV Risk and Crisis Management and more. Global HPV Communication Website for HPV Vaccination Promotion
  20. Laura Brennan was diagnosed with terminal cervical cancer in 2016. Following her diagnosis, she worked tirelessly to help others avoid this devastating disease by telling her story and spreading the facts about HPV and the vaccine that can prevent it. Laura passed away in March 2019 at age 26, but her message lives on.
  21. Description of the pertussis immunization program in pregnancy in Murcia´s Region
  22. MMR immunization campaign Murciasalud undertook in migrant adults and it is still ongoing
  23. Description of the campaign we conducted to promote HPV vaccination in preadolescent women
  24. This resource describes all the aspects of the pertussis immunization program in pregnancy.
  25. The Melbourne Vaccine Education Centre (MVEC) is an online initiative which provides up-to-date immunisation information for healthcare professionals, parents and the public. MVEC content aims to address common queries around vaccines and to promote the benefits of immunisation for both children and adults.
  26. Dengue vaccines have been under development since the 1940s, but due to the limited appreciation of global dengue disease burden and of the potential markets for dengue vaccines, the industry’s interest languished throughout much of the 20th century. In recent years, however, the development of dengue vaccines has accelerated dramatically. Sanofi Pasteur’s Dengvaxia® became the first dengue vaccine to be licensed for use in 2015. Today, several other vaccines are in various stages of advanced development, with clinical trials currently underway. Vaccine development for dengue is particularly challenging because dengue fever is caused by one of four related, but distinct, virus serotypes (DENV 1-4). While recovery from infection by one virus provides lifelong immunity against that virus, it provides only partial and transient immunity against the other three. For vaccine development, this means that an effective vaccine against dengue needs to be tetravalent, providing protection against all four dengue viruses. Dengue vaccines will complement, but not replace, prevention methods, such as vector control, already in place. According to the WHO, drawing on the experiences of other vaccine-preventable vector-borne diseases, effective surveillance, prevention and outbreak response tools (vector control and vaccines) must continue to complement each other in reducing the burden of the disease.
  27. Serie of questions and answers such as : What is RTS,S/AS01? What makes RTS,S different from malaria vaccine candidates currently under development? What is the efficacy of the RTS,S vaccine?
  28. The efficacy and safety of the RTS,S/AS01 candidate malaria vaccine during 18 months of follow-up have been published previously. Herein, we report the final results from the same trial, including the efficacy of a booster dose.
  1. Load more activity
  • Newsletter

    Want to keep up to date with all our latest news and information?

    Sign Up
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. - Terms of Use - Privacy Policy - Guidelines